Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00196_DB00726_nanopub.RA6e6Hm1-aF-xzvj5rbPl-yFDY2VNnqrY382ZGD6UPe3Y#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00196_DB00726 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00196_DB00726 label "DDI between Fluconazole and Trimipramine - Additive QTc-prolongation may occur, increasing the risk of serious ventricular arrhythmias. Fluconazole, a strong CYP2C19 inhibitor, may also decrease the metabolism and clearance of Trimipramine, a CYP2C19 substrate. Concomitant therapy should be used with caution. [drugbank_resource:DB00196_DB00726]" assertion.
- drugbank_resource:DB00196_DB00726 identifier "drugbank_resource:DB00196_DB00726" assertion.
- drugbank_resource:DB00196_DB00726 title "DDI between Fluconazole and Trimipramine - Additive QTc-prolongation may occur, increasing the risk of serious ventricular arrhythmias. Fluconazole, a strong CYP2C19 inhibitor, may also decrease the metabolism and clearance of Trimipramine, a CYP2C19 substrate. Concomitant therapy should be used with caution." assertion.
- drugbank:DB00726 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00196_DB00726 assertion.
- drugbank:DB00196 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00196_DB00726 assertion.